[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (24,942)

Search Parameters:
Keywords = skin

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
13 pages, 813 KiB  
Article
Development of a Wearable Electromyographic Sensor with Aerosol Jet Printing Technology
by Stefano Perilli, Massimo Di Pietro, Emanuele Mantini, Martina Regazzetti, Pawel Kiper, Francesco Galliani, Massimo Panella and Dante Mantini
Bioengineering 2024, 11(12), 1283; https://doi.org/10.3390/bioengineering11121283 - 17 Dec 2024
Abstract
Electromyographic (EMG) sensors are essential tools for analyzing muscle activity, but traditional designs often face challenges such as motion artifacts, signal variability, and limited wearability. This study introduces a novel EMG sensor fabricated using Aerosol Jet Printing (AJP) technology that addresses these limitations [...] Read more.
Electromyographic (EMG) sensors are essential tools for analyzing muscle activity, but traditional designs often face challenges such as motion artifacts, signal variability, and limited wearability. This study introduces a novel EMG sensor fabricated using Aerosol Jet Printing (AJP) technology that addresses these limitations with a focus on precision, flexibility, and stability. The innovative sensor design minimizes air interposition at the skin–electrode interface, thereby reducing variability and improving signal quality. AJP enables the precise deposition of conductive materials onto flexible substrates, achieving a thinner and more conformable sensor that enhances user comfort and wearability. Performance testing compared the novel sensor to commercially available alternatives, highlighting its superior impedance stability across frequencies, even under mechanical stress. Physiological validation on a human participant confirmed the sensor’s ability to accurately capture muscle activity during rest and voluntary contractions, with clear differentiation between low and high activity states. The findings highlight the sensor’s potential for diverse applications, such as clinical diagnostics, rehabilitation, and sports performance monitoring. This work establishes AJP technology as a novel approach for designing wearable EMG sensors, providing a pathway for further advancements in miniaturization, strain-insensitive designs, and real-world deployment. Future research will explore optimization for broader applications and larger populations. Full article
12 pages, 2269 KiB  
Article
Immunomodulatory Properties of Multi-Strain Postbiotics on Human CD14+ Monocytes
by Kyle D. Roberts, Sadia Ahmed, Erin San Valentin, Luca Di Martino, Thomas S. McCormick and Mahmoud A. Ghannoum
Life 2024, 14(12), 1673; https://doi.org/10.3390/life14121673 - 17 Dec 2024
Abstract
The ability of probiotics, comprising live microbiota, to modulate the composition of intestinal microbiomes has been connected to modulation of the central nervous system (Gut–Brain axis), neuroendocrine system (Gut–Skin axis), and immune response (Gut–Immune axis). Less information is known regarding the ability of [...] Read more.
The ability of probiotics, comprising live microbiota, to modulate the composition of intestinal microbiomes has been connected to modulation of the central nervous system (Gut–Brain axis), neuroendocrine system (Gut–Skin axis), and immune response (Gut–Immune axis). Less information is known regarding the ability of postbiotics (cell wall components and secreted metabolites derived from live organisms) to regulate host immunity. In the present study, we tested postbiotics comprising single strains of bacteria and yeast (Lactobacillus acidophilus 16axg, Lacticaseibacillus rhamnosus 18fx, Saccharomyces cerevisiae var. boulardii 16mxg) as well as combinations of multiple strains for their ability to stimulate cytokine production by human CD14+ monocytes. We quantified cytokine gene and protein expression levels in monocytes following stimulation with postbiotics. Both heat-killed L. acidophilus and L. rhamnosus stimulated naïve monocytes without significant differences between them. Heat-killed S. boulardii stimulated less cytokine production compared to postbiotic bacteria at the same concentration. Interestingly, the addition of heat-killed yeast to heat-killed L. acidophilus and L. rhamnosus resulted in an enhancement of immune stimulation. Thus, heat-killed postbiotics have immune-modulating potential, particularly when bacteria and yeast are combined. This approach may hold promise for developing targeted interventions that can be fine-tuned to modulate host immune response with beneficial health impact. Full article
(This article belongs to the Section Microbiology)
Show Figures

Figure 1

Figure 1
<p>CD14<sup>+</sup> monocytes have increased expression of proinflammatory genes following postbiotic stimulation, followed by increased gene expression of anti-inflammatory signals. (<b>A</b>). Time course of <span class="html-italic">TNFα</span>, <span class="html-italic">IL-6</span>, and <span class="html-italic">IL-10</span> expression in CD14<sup>+</sup> monocytes up to 24 h after exposure to heat-killed postbiotics. Points indicate the sample mean for each timepoint; error bars represent the mean ± standard deviation. The highlighted ribbon indicates the range between the maximum and minimum values observed at each timepoint over 24 h. The red dashed line indicates the normalized level of gene expression in the untreated control. (<b>B</b>). <span class="html-italic">TNFα</span> gene expression in CD14<sup>+</sup> monocytes cultured with heat-killed postbiotics after 2 h. (<b>C</b>). <span class="html-italic">IL-6</span> gene expression in CD14<sup>+</sup> monocytes cultured with heat-killed postbiotics after 4 h. (<b>D</b>). <span class="html-italic">IL-10</span> gene expression in CD14<sup>+</sup> monocytes cultured with heat-killed postbiotics after 8 h. For (<b>B</b>–<b>D</b>), error bars represent the sample mean ± standard deviation. Colors indicate the treatment group, while individual data points represent individual donors (<span class="html-italic">n</span> = 5 per treatment). The sample means were compared using a repeated-measures ANOVA with an applied Greenhouse–Geisser correction for within-subject factors. An adjusted <span class="html-italic">p</span>-value of <span class="html-italic">p</span> &lt; 0.05 was considered significant.</p>
Full article ">Figure 2
<p>Differential cytokine production from CD14<sup>+</sup> monocytes cultured with heat-killed postbiotics after 24 h. (<b>A</b>–<b>C</b>) Principal component analysis of supernatants of CD14<sup>+</sup> monocytes 24 h after stimulation with heat-killed postbiotics. Colors indicate the treatment group, while individual data points represent individual donors (<span class="html-italic">n</span> = 6 per treatment). (<b>D</b>) Heatmap with a complete linkage hierarchical clustering for scaled cytokines of interest. Each break in the heatmap represents a different treatment, and each row is labeled by donor number.</p>
Full article ">Figure 3
<p>The inclusion of <span class="html-italic">S. boulardii</span> in combination with <span class="html-italic">Lactobacillus sp</span>. increases chemokine abundance in the supernatant of primary CD14<sup>+</sup> monocytes following 24 h of co-culture with heat-killed postbiotics. (<b>A</b>) <span class="html-italic">CCL4</span> fluorescent intensity after 24 h culture of CD14<sup>+</sup> monocytes stimulated with heat-killed bacteria. (<b>B</b>) <span class="html-italic">CCL5</span> fluorescent intensity after 24 h culture of CD14<sup>+</sup> monocytes cultured with heat-killed bacteria. (<b>C</b>) <span class="html-italic">CXCL1</span> fluorescent intensity after 24 h co-culture of CD14<sup>+</sup> monocytes with heat-killed bacteria. For (<b>A</b>–<b>C</b>), individual colored points represent individual donors (<span class="html-italic">n</span> = 6), the thick colored line indicates the sample mean for all donors, and error bars represent the sample mean ± standard deviation. The sample means were compared using a repeated-measures ANOVA with an applied Greenhouse–Geisser correction for within-subject factors. An adjusted <span class="html-italic">p</span>-value of <span class="html-italic">p</span> &lt; 0.05 was considered significant.</p>
Full article ">Figure 4
<p>Cytokine production by primary CD14<sup>+</sup> monocytes after 24 h of co-culture with heat-killed postbiotics. (<b>A</b>) <span class="html-italic">TNFα</span> fluorescence intensity. (<b>B</b>) <span class="html-italic">IL-6</span> fluorescence intensity. (<b>C</b>) <span class="html-italic">IL-10</span> fluorescence intensity. (<b>D</b>) <span class="html-italic">IL-1α</span> fluorescence intensity. (<b>E</b>) <span class="html-italic">IL-1β</span> fluorescence intensity. (<b>F</b>) IL-1 receptor antagonist fluorescence intensity. For (<b>A</b>–<b>F</b>), individual colored points represent individual donors, the thick colored line indicates the sample mean for all donors (<span class="html-italic">n</span> = 6), and error bars represent the sample mean ± standard deviation. The sample means were compared using a repeated-measures ANOVA with an applied Greenhouse–Geisser correction for within-subject factors. An adjusted <span class="html-italic">p</span>-value of <span class="html-italic">p</span> &lt; 0.05 was considered significant.</p>
Full article ">
29 pages, 1043 KiB  
Review
The Nutrient–Skin Connection: Diagnosing Eating Disorders Through Dermatologic Signs
by Efstathios Rallis, Kleomenis Lotsaris, Vasiliki-Sofia Grech, Niki Tertipi, Eleni Sfyri and Vassiliki Kefala
Nutrients 2024, 16(24), 4354; https://doi.org/10.3390/nu16244354 - 17 Dec 2024
Abstract
The interplay between nutrition and skin health provides a crucial lens for understanding, diagnosing, and managing eating disorders (EDs) such as anorexia nervosa (AN), bulimia nervosa (BN), and binge-eating disorder (BED). This review explores the dermatological manifestations resulting from the nutritional deficiencies commonly [...] Read more.
The interplay between nutrition and skin health provides a crucial lens for understanding, diagnosing, and managing eating disorders (EDs) such as anorexia nervosa (AN), bulimia nervosa (BN), and binge-eating disorder (BED). This review explores the dermatological manifestations resulting from the nutritional deficiencies commonly associated with EDs, including conditions like hair loss, xerosis, and brittle nails. These changes in the skin and its appendages often reflect deeper systemic dysfunctions, such as deficiencies in essential micronutrients (zinc, iron, and vitamins A and C), hormonal imbalances, and electrolyte disturbances. Recognizing these dermatological signs as diagnostic tools is vital for the early identification and intervention of EDs. By integrating dermatological observations with psychiatric and nutritional care, a holistic, multidisciplinary approach can be developed to address both the physical and psychological complexities of EDs. This review highlights the critical role of these skin-related markers in promoting timely diagnosis and effective treatment. To examine the relationship between specific nutrients and dermatological manifestations in EDs, a systematic review of three electronic databases—PubMed, Google Scholar, and ResearchGate—was conducted. The findings underline the importance of early recognition of these skin symptoms for effective management. Collaborative care involving dermatologists, psychiatrists, and nutritionists is essential for diagnosing and treating EDs. Such integrated efforts ensure a comprehensive approach to these multifaceted conditions, ultimately improving patient outcomes and enhancing overall care. Full article
(This article belongs to the Section Nutrition and Public Health)
19 pages, 3038 KiB  
Review
Natural Products as Modulators of Aryl Hydrocarbon Receptor Signaling in Atopic Dermatitis Management
by Jangho Lee, Hyo-Kyoung Choi, Hee Soon Shin and Gun-Dong Kim
Molecules 2024, 29(24), 5951; https://doi.org/10.3390/molecules29245951 - 17 Dec 2024
Abstract
Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by immune dysregulation, skin barrier dysfunction, and a significant patient burden. Recent studies have highlighted the aryl hydrocarbon receptor (AhR) as a promising therapeutic target for AD management because of its pivotal role [...] Read more.
Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by immune dysregulation, skin barrier dysfunction, and a significant patient burden. Recent studies have highlighted the aryl hydrocarbon receptor (AhR) as a promising therapeutic target for AD management because of its pivotal role in modulating immune responses and maintaining skin barrier integrity. The dysfunction of the AhR pathway has been linked to AD pathogenesis, emphasizing the need for therapies that can restore its regulatory functions. Natural products have emerged as potential modulators of the AhR and are effective and safe alternatives to conventional treatments. Compounds such as curcumin, resveratrol, quercetin, and microbial metabolites have demonstrated the ability to activate AhR, reduce inflammation, and promote skin barrier function. These natural agents have fewer side effects and enhance patient compliance compared with conventional therapies, making them attractive candidates for long-term AD management. The integration of natural products targeting the AhR pathway provides a multifaceted approach that alleviates symptoms, addresses underlying disease mechanisms, and promotes sustainable improvements in skin health. This review highlights the therapeutic potential of natural AhR modulators and their potential roles in enhancing patient outcomes through novel integrative treatment strategies. Full article
Show Figures

Figure 1

Figure 1
<p>Pathogenesis of AD. AD is caused by genetic variations and repeated exposure to harmful substances including environmental pollutants, bacteria, and microbes. AD is developed by hypersensitivity or unbridled immune responses mediated by activated immune cells including eosinophils, mast cells, Langerhans cells, and T lymphocytes, and it becomes chronic and worsens due to skin barrier dysfunction and moisture loss. C-C motif chemokine ligand 2: CCL2; desmocollin 1: DSC1; filaggrin: FLG; intercellular adhesion molecule 1: ICAM1; interferon gamma: IFNγ; immunoglobulin E: IgE; interleukin: IL; type 2 innate lymphoid cell: ILC2; keratin 1: KRT1; matrix metalloproteinase: MMP; nitric oxide: NO; helper T: Th; tumor necrosis factor alpha: TNFα. Created with <a href="http://BioRender.com" target="_blank">BioRender.com</a>. Accessed on 5 November 2024.</p>
Full article ">Figure 2
<p>AhR signaling pathways as a therapeutic target for AD. AhR is activated by a ligand and is associated with various transcription factors or signaling pathways to regulate skin barrier function and suppress oxidative stress and inflammatory responses. Aryl hydrocarbon receptor: AhR; aryl hydrocarbon receptor nuclear translocator: ARNT; cytochrome P450 family 1 subfamily A member 1: CYP1A1; desmocollin 1: DSC1; filaggrin: FLG; intercellular adhesion molecule 1: ICAM1; interferon gamma: IFNγ; immunoglobulin E: IgE; interleukin: IL; type 2 innate lymphoid cell: ILC2; keratin 1: KRT1; ligand: L; loricrin: LOR; signal transducer and activator of transcription: STAT; matrix metalloproteinase: MMP; nitric oxide: NO; NAD(P)H quinone dehydrogenase 1: NQO1; nuclear factor erythroid 2-related factor 2: NRF2; ovo-like transcriptional repressor 1: OVOL1; retinoic acid-related orphan receptor gamma t: RORγt; helper T: Th; tumor necrosis factor alpha: TNFα; ultraviolet B: UVB. Created with BioRender.com. Accessed on 5 November 2024.</p>
Full article ">Figure 3
<p>Chemical structures of potential AhR-modulating natural products. Indole-3-carboxaldehyde is a major compound in both Bojungikgi-tang (BJIKT) and <span class="html-italic">Bacillus</span> ferment. Syringic acid and kuromanin are major compounds in fermented blueberry and black rice (FBBR). EGCG, Epigallocatechin gallate. The chemical structures were generated using ChemDraw (ver. 23.1.1).</p>
Full article ">
10 pages, 12001 KiB  
Case Report
Endocrine Mucin-Producing Sweat Gland Carcinoma (EMPSGC) in a Dog: Immunohistochemical Characterization
by Warisraporn Tangchang, Gi-young Jung, Jun-yeop Song, Poornima Kumbukgahadeniya, Dae-hyun Kim, Hyo-jung Kwon and Hwa-young Son
Animals 2024, 14(24), 3637; https://doi.org/10.3390/ani14243637 - 17 Dec 2024
Abstract
A seven-year-old spayed female dog presented with multiple, small oval-shaped masses on the abdominal skin. The excised tissue was submitted for histopathological evaluation. Routine histology revealed basaloid nodules with stippled chromatin and pleomorphic nuclei. Morphologically, the tumor resembled a solid papillary carcinoma of [...] Read more.
A seven-year-old spayed female dog presented with multiple, small oval-shaped masses on the abdominal skin. The excised tissue was submitted for histopathological evaluation. Routine histology revealed basaloid nodules with stippled chromatin and pleomorphic nuclei. Morphologically, the tumor resembled a solid papillary carcinoma of the breast or an endocrine mucin-producing sweat gland carcinoma (EMPSGC). EMPSGC is a rare neuroendocrine-differentiated neoplasm. This study aimed to compare different immunohistochemical markers for distinguishing between canine sweat gland carcinoma (SGC) and mammary gland carcinoma (MGC). CK19 and Sox9 were useful in identifying SGC. Additionally, the tumor was positive for CK5, AE1/AE3+CK8/18, p63, vimentin, E-cadherin, and synaptophysin, while estrogen receptor staining was negative. The final diagnosis of canine EMPSGC was based on the tumor’s morphological and neuroendocrine immunohistopathological features. Our report provides the first detailed description of a canine EMPSGC, an exceedingly rare tumor in dogs. Full article
(This article belongs to the Section Veterinary Clinical Studies)
Show Figures

Figure 1

Figure 1
<p>Gross finding figure. (<b>a</b>) The skin shows bluish discoloration, and numerous nodules form irregular mass that protrude into the skin of case 1. (<b>b</b>) Removed tumor mass from case 1; the mass is firmly adhered to the skin and subcutaneous connective tissue. (<b>c</b>) A removed mass (7 cm × 6 cm) in the right 2nd mammary gland from case 2.</p>
Full article ">Figure 2
<p>Histological examination of both cases. (<b>a</b>) The tumor displayed a thickened stroma of lobular. The multilobular tumor exhibits mucin secretion in the cystic and solid areas, as observed in case 1, Mag. = ×200. (<b>b</b>) Within the lobules, peripheral palisading was identified in some areas. Nuclei were bland with moderate pleomorphism and diffusely stippled chromatin from case 1, Mag. = ×400. (<b>c</b>) The irregular proliferation of small glands of case 2, Mag. = ×100. (<b>d</b>) The tubules were lined by a single layer of cuboidal or columnar cell hyperplasia with atypia of case 2, Mag. = ×400, hematoxylin and eosin (HE).</p>
Full article ">Figure 3
<p>Immunoreactivity of cytokeratin (CK). Case 1 (sweat gland carcinoma), (<b>a</b>) luminobasal tumor cells were positive for CK5, (<b>b</b>) luminal tumor cells were positive for AE1/AE3+CK8/18, (<b>c</b>) CK19 was cytoplasmic, and cell membrane expression. Case 2 (mammary gland carcinoma), (<b>d</b>) CK5 was positive, (<b>e</b>) AE1/AE3+CK8/18 and (<b>f</b>) CK19 showed no immunoreactivity, immunohistochemistry (IHC).</p>
Full article ">Figure 4
<p>Immunoreactivity of myoepithelial and other markers. Case 1 (sweat gland carcinoma), (<b>a</b>) nuclear was positive for p63, (<b>b</b>) cytoplasmic areas were positive for vimentin, (<b>c</b>) Sox9 found nuclear expression. Case 2 (mammary gland carcinoma), (<b>d</b>) p63 and (<b>e</b>) vimentin were positive in myoepithelial cells, and (<b>f</b>) Sox9 was negative expression, immunohistochemistry (IHC).</p>
Full article ">Figure 5
<p>Immunoreactivity of endocrine and other markers. Case 1 (sweat gland carcinoma), (<b>a</b>) membranous and cytoplasmic areas were positive for E-cadherins, (<b>b</b>) cytoplasmic expression of synaptophysin, (<b>c</b>) nuclear was negative for estrogen. Case 2 (mammary gland carcinoma), (<b>d</b>) E-cadherins showed weak expression, (<b>e</b>) synaptophysin was cytoplasmic expression, and (<b>f</b>) nuclear cell showed positive for estrogen, immunohistochemistry (IHC).</p>
Full article ">
21 pages, 8114 KiB  
Article
Investigation of the Flexural Behavior and Damage Mechanisms of Flax/Cork Sandwich Panels Manufactured by Liquid Thermoplastic Resin
by Anas Ait Talaoul, Mustapha Assarar, Wajdi Zouari, Rezak Ayad, Brahim Mazian and Karim Behlouli
J. Compos. Sci. 2024, 8(12), 539; https://doi.org/10.3390/jcs8120539 - 17 Dec 2024
Abstract
This study investigates the flexural behavior of three sandwich panels composed of an agglomerated cork core and skins made up of cross-ply [0,90]2 flax or glass layers with areal densities of 100 and 300 g/m2. They are designated by SF100, [...] Read more.
This study investigates the flexural behavior of three sandwich panels composed of an agglomerated cork core and skins made up of cross-ply [0,90]2 flax or glass layers with areal densities of 100 and 300 g/m2. They are designated by SF100, SF300, and SG300, where S, F, and G stand for sandwich material, flax fiber, and glass fiber, respectively. The three sandwich materials were fabricated in a single step using vacuum infusion with the liquid thermoplastic resin Elium®. Specimens of these sandwich materials were subjected to three-point bending tests at five span lengths (80, 100, 150, 200, and 250 mm). Each specimen was equipped with two piezoelectric sensors to record acoustic activity during the bending, facilitating the identification of the main damage mechanisms leading to flexural failure. The acoustic signals were analyzed to first track the initiation and propagation of damage and, second, to correlate these signals with the mechanical behavior of the sandwich materials. The obtained results indicate that SF300 exhibits 60% and 49% higher flexural and shear stiffness, respectively, than SG300. Moreover, a comparison of the specific mechanical properties reveals that SF300 offers the best compromise in terms of the flexural properties. Moreover, the acoustic emission (AE) analysis allowed the identification of the main damage mechanisms, including matrix cracking, fiber failure, fiber/matrix, and core/skin debonding, as well as their chronology during the flexural tests. Three-dimensional micro-tomography reconstructions and scanning electron microscope (SEM) observations were performed to confirm the identified damage mechanisms. Finally, a correlation between these observations and the AE signals is proposed to classify the damage mechanisms according to their corresponding amplitude ranges. Full article
(This article belongs to the Special Issue Sustainable Biocomposites, Volume II)
Show Figures

Figure 1

Figure 1
<p>Layer stacking of the three sandwich panels studied in this work.</p>
Full article ">Figure 2
<p>UD-F100 laminate in the tensile test.</p>
Full article ">Figure 3
<p>SG300 sample in the three-point bending test.</p>
Full article ">Figure 4
<p>Tensile curves of (<b>a</b>) the UD laminates and (<b>b</b>) the [0,90]<sub>2</sub> sandwich skins.</p>
Full article ">Figure 5
<p>Load–deflection curves of (<b>a</b>) SF100, (<b>b</b>) SG300, and (<b>c</b>) SF300 from the three-point bending tests.</p>
Full article ">Figure 6
<p>Determination of the equivalent flexural and shear stiffnesses of SF100 (<b>a</b>), SG300 (<b>b</b>), and SF300 (<b>c</b>).</p>
Full article ">Figure 7
<p>Radar diagram of SF100, SF300, and SG300, as tested through three-point bending.</p>
Full article ">Figure 8
<p>Acoustic events of SF100 (<b>a</b>,<b>b</b>), SG300 (<b>c</b>,<b>d</b>), and SF300 (<b>e</b>,<b>f</b>) in synchronization with the applied load during the three-point bending tests, with support spans of 100 mm (<b>a</b>,<b>c</b>,<b>e</b>) and 250 mm (<b>b</b>,<b>d</b>,<b>f</b>).</p>
Full article ">Figure 9
<p>Evolution of the cumulative number of hits during the three-point bending tests.</p>
Full article ">Figure 10
<p>Acoustic signal classification of SF100, SF300, and SG300.</p>
Full article ">Figure 11
<p>SEM observations of matrix and core cracking in SF100, SF300, and SG300.</p>
Full article ">Figure 12
<p>SEM observations of damage to the skin/core interfaces.</p>
Full article ">Figure 13
<p>SEM observations of fiber damage.</p>
Full article ">Figure 14
<p>SEM observations of damage inside fibers.</p>
Full article ">Figure 15
<p>Micro-tomographic observations of the (<b>a</b>) SF100 and (<b>b</b>) SF300 specimens near the loading point for L = 100 mm.</p>
Full article ">Figure 16
<p>Micro-tomographic observations of the (<b>a</b>) SF300 and (<b>b</b>) SG300 specimens for L = 250 mm.</p>
Full article ">
17 pages, 6290 KiB  
Article
Accuracy of the Apple Watch Series 9 for Measures of Energy Expenditure and Heart Rate at Rest and During Exercise: Impact of Skin Pigmentation
by Sydney E. Chase, Rebecca G. Liddell, Chloe L. McGonagle and Stephen J. Ives
J. Funct. Morphol. Kinesiol. 2024, 9(4), 275; https://doi.org/10.3390/jfmk9040275 - 17 Dec 2024
Abstract
Background: The Apple Watch provides promising health data that could aid in increasing exercise adherence; regular exercise can help individuals manage and prevent diseases such as obesity and cardiovascular disease. However, the impact of skin pigmentation on the accuracy of the Apple Watch [...] Read more.
Background: The Apple Watch provides promising health data that could aid in increasing exercise adherence; regular exercise can help individuals manage and prevent diseases such as obesity and cardiovascular disease. However, the impact of skin pigmentation on the accuracy of the Apple Watch Series 9 for measures of energy expenditure (EE) and heart rate (HR) is unknown. Purpose: The purpose of this study was to determine the accuracy of the Apple Watch Series 9 on various skin pigmentations for measures of EE and HR. Methods: Thirty young, healthy individuals were assigned to one of three groups based on their scores on the Fitzpatrick skin survey. Participants completed a 10 min treadmill protocol with varying speeds and inclines while wearing an Apple Watch Series 9, a two-way non-rebreathing mouthpiece connected to a Parvo Medics metabolic cart, and a Polar H7 chest strap to measure EE and HR. Results: Overall, EE was found to be inconsistent for all skin pigmentation groups. However, for HR, the Apple Watch Series 9 was more variable (i.e., less accurate) for darker skin pigmentations compared to lighter skin pigmentations. Conclusions: The Apple Watch Series 9 was found to vary in both EE and HR measures from criterion across intensity and skin pigmentation, with greater discrepancies for individuals in Group 3 for measures of HR. Further investigation might aim to study the impact of skin pigmentations and wrist subcutaneous fat on the accuracy of the latest Apple Watch Series 9 for measures of EE and HR. Full article
(This article belongs to the Special Issue Understanding Sports-Related Health Issues, 2nd Edition)
Show Figures

Figure 1

Figure 1
<p>Overview of the experimental design.</p>
Full article ">Figure 2
<p>Energy expenditure response in calories per min (kcal/min) of the college-aged participants (N = 30) from the Parvo Medics (panel <b>A</b>) or the Apple Watch Series 9 (panel <b>B</b>) during each stage of the 10-min treadmill protocol. Data presented as means ± standard deviation. * Significant difference from 0 min (<span class="html-italic">p</span> &lt; 0.05). # Significant difference from 2 min (<span class="html-italic">p</span> &lt; 0.05). <span>$</span> Significant difference from 4 min (<span class="html-italic">p</span> &lt; 0.05). % Significant difference from 6 min (<span class="html-italic">p</span> &lt; 0.05). &amp; Significant difference from 8 min (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 2 Cont.
<p>Energy expenditure response in calories per min (kcal/min) of the college-aged participants (N = 30) from the Parvo Medics (panel <b>A</b>) or the Apple Watch Series 9 (panel <b>B</b>) during each stage of the 10-min treadmill protocol. Data presented as means ± standard deviation. * Significant difference from 0 min (<span class="html-italic">p</span> &lt; 0.05). # Significant difference from 2 min (<span class="html-italic">p</span> &lt; 0.05). <span>$</span> Significant difference from 4 min (<span class="html-italic">p</span> &lt; 0.05). % Significant difference from 6 min (<span class="html-italic">p</span> &lt; 0.05). &amp; Significant difference from 8 min (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 3
<p>Heart rate response in beats per min (bpm) of the college-aged participants (N = 30) from the Polar H7 (panel <b>A</b>) or the Apple Watch Series 9 (panel <b>B</b>) during each stage of the 10-min treadmill protocol. Data presented as means ± standard deviation. * Significant difference from 0 min (<span class="html-italic">p</span> &lt; 0.05). # Significant difference from 2 min (<span class="html-italic">p</span> &lt; 0.05). <span>$</span> Significant difference from 4 min (<span class="html-italic">p</span> &lt; 0.05). % Significant difference from 6 min (<span class="html-italic">p</span> &lt; 0.05). &amp; Significant difference from 8 min (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 3 Cont.
<p>Heart rate response in beats per min (bpm) of the college-aged participants (N = 30) from the Polar H7 (panel <b>A</b>) or the Apple Watch Series 9 (panel <b>B</b>) during each stage of the 10-min treadmill protocol. Data presented as means ± standard deviation. * Significant difference from 0 min (<span class="html-italic">p</span> &lt; 0.05). # Significant difference from 2 min (<span class="html-italic">p</span> &lt; 0.05). <span>$</span> Significant difference from 4 min (<span class="html-italic">p</span> &lt; 0.05). % Significant difference from 6 min (<span class="html-italic">p</span> &lt; 0.05). &amp; Significant difference from 8 min (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 4
<p>The agreement between Apple Watch Series 9 and Parvo Medics EE for all timepoints for Group 1 (panel <b>A</b>; M = −0.884), Group 2 (panel <b>B</b>; M = −1.020), and Group 3 (panel <b>C</b>; M = −8.529).</p>
Full article ">Figure 5
<p>The agreement between Apple Watch Series 9 and Polar H7 HR for all time points for Group 1 (panel <b>A</b>; M = −0.875), Group 2 (panel <b>B</b>; M = −3.169), and Group 3 (panel <b>C</b>; M = −8.354).</p>
Full article ">Figure 6
<p>The relationship between the Apple Watch Series 9 and Parvo Medics on measures of energy expenditure (EE) for rest (panel <b>A</b>; r = 0.495; <span class="html-italic">p</span> &lt; 0.001), 0 min (panel <b>B</b>; r = 0.095; <span class="html-italic">p</span> = 0.430), 2 min (panel <b>C</b>; r = 0.261; <span class="html-italic">p</span> = 0.220), 4 min (panel <b>D</b>; r = 0.535; <span class="html-italic">p</span> = 0.017), 6 min (panel <b>E</b>; r = 0.585; <span class="html-italic">p</span> = 0.002), 8 min (panel <b>F</b>; r = 0.554; <span class="html-italic">p</span> = 0.048), 10 min (panel <b>G</b>; r = 0.520; <span class="html-italic">p</span> = 0.003), and post-rest (panel <b>H</b>; r = 0.641; <span class="html-italic">p</span> &lt; 0.001) in the participants in the study (N = 30). Data presented as values. * Statistical significance <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 7
<p>The relationship between the Apple Watch Series 9 and Polar H7 on measures of heart rate (HR) at rest (panel <b>A</b>; r = 0.365; <span class="html-italic">p</span> &lt; 0.001), 0 min (panel <b>B</b>; r = 0.635; <span class="html-italic">p</span> &lt; 0.001), 2 min (panel <b>C</b>; r = 0.431; <span class="html-italic">p</span> &lt; 0.001), 4 min (panel <b>D</b>; r = 0.819; <span class="html-italic">p</span> &lt; 0.001), 6 min (panel <b>E</b>; r = 0.732; <span class="html-italic">p</span> &lt; 0.001), 8 min (panel <b>F</b>; r = 0.690; <span class="html-italic">p</span> &lt; 0.001), 10 min (panel <b>G</b>; r = 0.732; <span class="html-italic">p</span> &lt; 0.001), and post-rest (panel <b>H</b>; r = 0.438; <span class="html-italic">p</span> &lt; 0.001) in the participants in the study (N = 30). Data presented as values. * Statistical significance <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 8
<p>The relationship between the Apple Watch Series 9 and Polar H7 on measures of heart rate (HR) at rest (panel <b>A</b>; r = 0.899; <span class="html-italic">p</span> = 0.006), 0 min (panel <b>B</b>; r = 0.902; <span class="html-italic">p</span> = 0.005), 2 min (panel <b>C</b>; r = 0.965; <span class="html-italic">p</span> &lt; 0.001), 4 min (panel <b>D</b>; r = 0.985; <span class="html-italic">p</span> &lt; 0.001), 6 min (panel <b>E</b>; r = 0.955; <span class="html-italic">p</span> &lt; 0.001), 8 min (panel <b>F</b>; r = 0.964; <span class="html-italic">p</span> &lt; 0.001), 10 min (panel <b>G</b>; r = 0.993; <span class="html-italic">p</span> &lt; 0.001), and post-rest (panel <b>H</b>; r = 0.986; <span class="html-italic">p</span> &lt; 0.001) in the Group 1 participants in the study (n = 7). Data presented as values. * Statistical significance <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 9
<p>The relationship between the Apple Watch Series 9 and Polar H7 on measures of heart rate (HR) for rest (panel <b>A</b>; r = 0.187; <span class="html-italic">p</span> = 0.093), 0 min (panel <b>B</b>; r = 0.531; <span class="html-italic">p</span> = 0.006), 2 min (panel <b>C</b>; r = 0.297; <span class="html-italic">p</span> = 0.048), 4 min (panel <b>D</b>; r = 0.881; <span class="html-italic">p</span> &lt; 0.001), 6 min (panel <b>E</b>; r = 0.810; <span class="html-italic">p</span> &lt; 0.001), 8 min (panel <b>F</b>; r = 0.959; <span class="html-italic">p</span> &lt; 0.001), 10 min (panel <b>G</b>; r = 0.995; <span class="html-italic">p</span> &lt; 0.001), and post-rest (panel <b>H</b>; r = 0.554; <span class="html-italic">p</span> = 0.002) in the Group 2 participants in the study (n = 17). Data presented as values. * Statistical significance <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 10
<p>The relationship between the Apple Watch Series 9 and Polar H7 on measures of heart rate (HR) for rest (panel <b>A</b>; r = 0.936; <span class="html-italic">p</span> = 0.006), 0 min (panel <b>B</b>; r = 0.964; <span class="html-italic">p</span> = 0.002), 2 min (panel <b>C</b>; r = 0.841; <span class="html-italic">p</span> = 0.050), 4 min (panel <b>D</b>; r = 0.786; <span class="html-italic">p</span> = 0.064), 6 min (panel <b>E</b>; r = −0.159; <span class="html-italic">p</span> = 0.763), 8 min (panel <b>F</b>; r = −0.336; <span class="html-italic">p</span> = 0.658), 10 min (panel <b>G</b>; r = −0.079; <span class="html-italic">p</span> = 1.000), and post-rest (panel <b>H</b>; r = −0.306; <span class="html-italic">p</span> = 0.827) in the Group 3 participants in the study (n = 6). Data presented as values. * Statistical significance <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 10 Cont.
<p>The relationship between the Apple Watch Series 9 and Polar H7 on measures of heart rate (HR) for rest (panel <b>A</b>; r = 0.936; <span class="html-italic">p</span> = 0.006), 0 min (panel <b>B</b>; r = 0.964; <span class="html-italic">p</span> = 0.002), 2 min (panel <b>C</b>; r = 0.841; <span class="html-italic">p</span> = 0.050), 4 min (panel <b>D</b>; r = 0.786; <span class="html-italic">p</span> = 0.064), 6 min (panel <b>E</b>; r = −0.159; <span class="html-italic">p</span> = 0.763), 8 min (panel <b>F</b>; r = −0.336; <span class="html-italic">p</span> = 0.658), 10 min (panel <b>G</b>; r = −0.079; <span class="html-italic">p</span> = 1.000), and post-rest (panel <b>H</b>; r = −0.306; <span class="html-italic">p</span> = 0.827) in the Group 3 participants in the study (n = 6). Data presented as values. * Statistical significance <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 11
<p>The relationship between the Apple Watch Series 9 and Parvo Medics on measures of energy expenditure (EE) for all time points for Group 1 (<b>A</b>; r = 0.674; <span class="html-italic">p</span> = &lt; 0.001), Group 2 (<b>B</b>; r = 0.706; <span class="html-italic">p</span> = &lt; 0.001), and Group 3 (<b>C</b>; r = 0.694; <span class="html-italic">p</span> &lt; 0.001). Data presented as values. * Statistical significance <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 12
<p>The relationship between the Apple Watch Series 9 and Polar H7 on measures of heart rate (HR) for all timepoints for Group 1 (<b>A</b>; r = 0.982; <span class="html-italic">p</span> &lt; 0.001), Group 2 (<b>B</b>; r = 0.802; <span class="html-italic">p</span> &lt; 0.001), and Group 3 (<b>C</b>; r = 0.675; <span class="html-italic">p</span> &lt; 0.001). Data presented as values. * Statistical significance <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">
20 pages, 3311 KiB  
Article
Novel Tripeptides as Tyrosinase Inhibitors: In Silico and In Vitro Approaches
by Michał Dymek, Dawid Warszycki, Sabina Podlewska and Elżbieta Sikora
Int. J. Mol. Sci. 2024, 25(24), 13509; https://doi.org/10.3390/ijms252413509 - 17 Dec 2024
Abstract
Tyrosinase is a key enzyme responsible for the formation of melanin (a natural skin pigment with ultraviolet-protection properties). However, some people experience melanin overproduction, so new, safe, and biocompatible enzyme inhibitors are sought. New tripeptide tyrosinase inhibitors were developed using molecular modeling. A [...] Read more.
Tyrosinase is a key enzyme responsible for the formation of melanin (a natural skin pigment with ultraviolet-protection properties). However, some people experience melanin overproduction, so new, safe, and biocompatible enzyme inhibitors are sought. New tripeptide tyrosinase inhibitors were developed using molecular modeling. A combinatorial library of tripeptides was prepared and docked to the mushroom tyrosinase crystal structure and investigated with molecular dynamics. Based on the results of calculations and expert knowledge, the three potentially most active peptides (CSF, CSN, CVL) were selected. Their in vitro properties were examined, and they achieved half-maximal inhibitory concentration (IC50) values of 136.04, 177.74, and 261.79 µM, respectively. These compounds attach to the binding pocket of tyrosinase mainly through hydrogen bonds and salt bridges. Molecular dynamics simulations demonstrated the stability of the peptid–tyrosinase complexes and highlighted the persistence of key interactions throughout the simulation period. The ability of these peptides to complex copper ions was also confirmed. The CSF peptide showed the highest chelating activity with copper. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay confirmed that none of the test tripeptides showed cytotoxicity toward the reconstructed human epidermis. Our results indicated that the developed tripeptides were non-toxic and effective tyrosinase inhibitors. They could be applied as raw materials in skin-brightening or anti-aging cosmetic products. Full article
(This article belongs to the Section Molecular Biophysics)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Multiple sequence alignment of tyrosinases from different species: humans (Human TYR); <span class="html-italic">Agaricus bisporus</span> (2Y9X); <span class="html-italic">Malus domestics</span> (6ELS); and <span class="html-italic">Ipomoea batatas</span> (1BT1). The figure shows a fragment of the sequence preserving the amino acids located near the active site and histidine residues responsible for copper coordination. The colors of cells correspond to the types of amino acids: green (polar); purple (acidic); red (basic); blue (hydrophobic); turquoise (polar and aromatic); orange and yellow (amino acids breaking the secondary structure). The asterisk (*) indicates the location of the specific amino acid number mentioned above.</p>
Full article ">Figure 2
<p>Binding interactions for CVL (<b>A</b>), CSF (<b>B</b>), and CSN (<b>C</b>) tripeptides within the 2Y9X binding site.</p>
Full article ">Figure 3
<p>Mapping of tyrosinase–ligand contacts for the selected tripeptides CVL (<b>A</b>), CSF (<b>B</b>), CSN (<b>C</b>) as a result of 1000-ns MD simulation. The symbols of amino acids forming contacts during the analysis are placed on the horizontal axis, and the corresponding interaction fraction is placed on the vertical axis. The colors in the charts correspond to different types of interactions: H-bonds (green); hydrophobic (purple); ionic (pink); or water bridges (blue). The interaction fraction represents the proportion of time-specific interactions maintained throughout the trajectory snapshots.</p>
Full article ">Figure 4
<p>Timeline representation of protein–ligand contacts for CVL (<b>A</b>), CSF (<b>B</b>), and CSN (<b>C</b>) tripeptides. Total number of specific protein–ligand contacts is shown in the top panels of each compound as dark-blue lines. The vertical axis of the bottom panels lists the amino acids of tyrosinase interacting with peptide inhibitors, whereas the horizontal axis is the time scale of the simulation (1000 ns). Darker shades of orange correspond to more abundant active pocket–inhibitor contacts in each trajectory frame.</p>
Full article ">Figure 5
<p>Interactions between ligand atoms and tyrosinase residues for CVL (<b>A</b>), CSF (<b>B</b>), and CSN (<b>C</b>) tripeptides (schematic). The contacts shown occurred &gt;30% of the simulation time. The colors of enzyme residues correspond to their chemical nature: polar (blue); negatively charged (orange); and hydrophobic (green). Copper atoms are represented as gray spheres. Percent values indicate the frequency of the interaction during analyses.</p>
Full article ">Figure 6
<p>Lineweaver–Burk plot for the inhibition of mushroom tyrosinase activity by the CSF peptide at different concentrations of the inhibitor (0, 37.2, 74.4, and 111.6 µM).</p>
Full article ">
12 pages, 2110 KiB  
Article
Combination of Topical Heparin and Levomenol in the Treatment of Atopic Dermatitis: A SCORing Atopic Dermatitis (SCORAD) Analysis
by Marie Hladíková and Mathias Schmidt
Dermato 2024, 4(4), 205-216; https://doi.org/10.3390/dermato4040018 - 17 Dec 2024
Viewed by 6
Abstract
Background/Objectives: A prior placebo-controlled, double-blind clinical study demonstrated the superiority of a topical combination of heparin and levomenol over the control and single active constituents. The effect on pruritus and the total SCORAD index were used to evaluate efficacy, but not the effect [...] Read more.
Background/Objectives: A prior placebo-controlled, double-blind clinical study demonstrated the superiority of a topical combination of heparin and levomenol over the control and single active constituents. The effect on pruritus and the total SCORAD index were used to evaluate efficacy, but not the effect on the individual SCORAD items. This analysis investigates the overall efficacy of the treatment and the relative contributions of heparin and levomenol to symptom relief in atopic dermatitis, including the effects on the affected body area and its implications for sleeplessness. Methods: The ITT group (combination group A: n = 79; levomenol group B: n = 80; heparin group C: n = 78; placebo group D: n = 41) of the previously published study was re-analysed. Results: The combination significantly improved symptoms such as erythema, edema/papulation, excoriations, and skin dryness compared to the control after eight weeks of treatment. No significant differences were observed for oozing/crust and lichenification among the active groups. Levomenol and heparin exhibited significant advantages over the control for erythema and excoriations, while heparin improved edema/papulation significantly. The inflamed body area significantly decreased using the combination or single active constituents, and sleeplessness significantly improved with the combination or with heparin alone compared to the control. Conclusions: These findings highlight the efficacy of the combination and individual active constituents in addressing specific symptoms of atopic dermatitis, providing insights into their therapeutic effects. The combination’s advantage over the control is most evident in improving excoriations, skin dryness, inflamed skin area, and sleeplessness, justifying its documented use as an intervention in the early stages of atopic dermatitis episodes. Full article
Show Figures

Figure 1

Figure 1
<p>Reduction in inflamed body area relative to baseline, after four and eight weeks of treatment (<span class="html-italic">p</span> value vs. control; * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> ≤ 0.01, *** <span class="html-italic">p</span> ≤ 0.001, **** <span class="html-italic">p</span> ≤ 0.0001).</p>
Full article ">Figure 2
<p>Within-group improvement in skin-related symptoms: (<b>A</b>) erythema; (<b>B</b>) edema/papulation; (<b>C</b>) excoriations; (<b>D</b>) oozing/crust formation; (<b>E</b>) lichenification; (<b>F</b>) dryness of unaffected skin (n.s.: not significant).</p>
Full article ">Figure 2 Cont.
<p>Within-group improvement in skin-related symptoms: (<b>A</b>) erythema; (<b>B</b>) edema/papulation; (<b>C</b>) excoriations; (<b>D</b>) oozing/crust formation; (<b>E</b>) lichenification; (<b>F</b>) dryness of unaffected skin (n.s.: not significant).</p>
Full article ">Figure 2 Cont.
<p>Within-group improvement in skin-related symptoms: (<b>A</b>) erythema; (<b>B</b>) edema/papulation; (<b>C</b>) excoriations; (<b>D</b>) oozing/crust formation; (<b>E</b>) lichenification; (<b>F</b>) dryness of unaffected skin (n.s.: not significant).</p>
Full article ">Figure 2 Cont.
<p>Within-group improvement in skin-related symptoms: (<b>A</b>) erythema; (<b>B</b>) edema/papulation; (<b>C</b>) excoriations; (<b>D</b>) oozing/crust formation; (<b>E</b>) lichenification; (<b>F</b>) dryness of unaffected skin (n.s.: not significant).</p>
Full article ">Figure 3
<p>Percentage of patients showing improvements from “severe” or “moderate” to “mild” or “absent” after eight weeks of treatment (* <span class="html-italic">p</span> ≤ 0.05, ** <span class="html-italic">p</span> ≤ 0.01, *** <span class="html-italic">p</span> ≤ 0.001, **** <span class="html-italic">p</span> ≤ 0.0001, # <span class="html-italic">p</span> = 0.05).</p>
Full article ">Figure 4
<p>Reduction in sleep loss during the study compared to baseline after four and eight weeks of treatment (* <span class="html-italic">p</span> &lt; 0.05, **** <span class="html-italic">p</span> ≤ 0.0001).</p>
Full article ">
13 pages, 2263 KiB  
Article
10(E)-Pentadecenoic Acid Inhibits Melanogenesis Partly Through Suppressing the Intracellular MITF/Tyrosinase Axis
by Min-Kyeong Lee, Kyoung Mi Moon, Su-Yeon Park, Jaeseong Seo, Ah-Reum Kim and Bonggi Lee
Antioxidants 2024, 13(12), 1547; https://doi.org/10.3390/antiox13121547 - 17 Dec 2024
Viewed by 65
Abstract
Melanogenesis, the biological process responsible for melanin synthesis, plays a crucial role in determining skin and hair color, photoprotection, and serving as a biomarker in various diseases. While various factors regulate melanogenesis, the role of fatty acids in this process remains underexplored. This [...] Read more.
Melanogenesis, the biological process responsible for melanin synthesis, plays a crucial role in determining skin and hair color, photoprotection, and serving as a biomarker in various diseases. While various factors regulate melanogenesis, the role of fatty acids in this process remains underexplored. This study investigated the anti-melanogenic properties of 10(E)-pentadecenoic acid (10E-PDA) through both in silico and in vitro analyses. SwissSimilarity was utilized to predict the functional properties of 10E-PDA by comparing it with structurally similar lipids known to exhibit anti-melanogenic effects. Subsequent in vitro experiments demonstrated that 10E-PDA significantly reduced melanin production and intracellular tyrosinase activity in α-MSH (melanocyte-stimulating hormone)-stimulated B16F10 melanoma cells without exhibiting significant cytotoxicity at concentrations up to 15 μM. Further mechanistic studies revealed that 10E-PDA inhibited the nuclear translocation of microphthalmia-associated transcription factor (MITF), consistent with the decrease observed in p-MITF protein levels. It also decreased the mRNA levels of tyrosinase-related proteins (TRP-1, TRP-2) and tyrosinase, while reducing the protein levels of TRP-1 and tyrosinase, but not TRP-2. These findings suggest that 10E-PDA exerts its anti-melanogenic effects by modulating the MITF/tyrosinase axis, presenting potential therapeutic implications for skin pigmentation disorders. Full article
(This article belongs to the Special Issue Antioxidants for Skin Health)
Show Figures

Figure 1

Figure 1
<p>Similarity analysis of 10E-PDA with other compounds. SwissSimilarity was used to compare 10E-PDA with structurally similar compounds to predict its potential functions in the skin. 10E-PDA, which contains a trans double bond between the 10th and 11th carbons, exhibited very close similarity to compounds such as palmitoleic acid, cis-vaccenic acid, oleic acid, myristoleic acid, α-linolenic acid, elaidic acid, gondoic acid, and linoleic acid, with similarity scores ranging from 0.998 to 0.999. Among these, several compounds, including palmitoleic acid, α-linolenic acid, and linoleic acid, are known to have anti-melanogenic properties.</p>
Full article ">Figure 2
<p>Effects of 10E-PDA on inhibiting melanogenesis in α-MSH-stimulated B16F10 melanoma cells. (<b>a</b>) B16F10, (<b>b</b>) HS68, and (<b>c</b>) HaCaT cells were treated with increasing concentrations of 10E-PDA (1–100 μM) for 24 h, after which cell viability was assessed (n = 4 per group). (<b>d</b>,<b>e</b>) B16F10 cells were pretreated with different concentrations of 10E-PDA (1–15 μM) or kojic acid (30 μM) for 1 h, followed by exposure to α-MSH (500 nM) for 6 days to measure melanin content (<b>d</b>) or for 3 days to examine tyrosinase activity (<b>e</b>). In both panels, the white bar represents the untreated control group without α-MSH stimulation, the black bar represents the α-MSH-stimulated control group, and the dark gray bars indicate the 10E-PDA-treated groups under α-MSH stimulation. In panel (<b>e</b>), the light gray bar represents the positive control group treated with kojic acid under α-MSH stimulation. Data are shown as mean ± SEM. <sup>###</sup> <span class="html-italic">p</span> &lt; 0.001 compared with the untreated control group, and * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001 compared with the α-MSH-treated group.</p>
Full article ">Figure 3
<p>Cell-free tyrosinase and antioxidant activities of 10E-PDA. (<b>a</b>) Tyrosinase activity of 10E-PDA was measured using a mushroom tyrosinase activity assay. (<b>b</b>) The antioxidant capacity of 10E-PDA was evaluated using DPPH radical scavenging activity. (<b>c</b>) The copper ion reduction capacity of 10E-PDA was determined using CUPRAC analysis, with results compared with the reference ascorbic acid. In all panels, the white bar represents the untreated control group, and the black bars indicate the 10E-PDA-treated groups at various concentrations (1–60 μM). Data are presented as mean ± standard error (n = 3). * <span class="html-italic">p</span> &lt; 0.05 compared with the untreated control group.</p>
Full article ">Figure 4
<p>Impact of 10E-PDA on gene and protein expression of melanogenesis-related targets. To analyze the effect of 10E-PDA on melanogenesis markers, before stimulation with α-MSH (500 nM) over six days, B16F10 melanoma cells were pre-treated with 10E-PDA at concentrations of 5 and 15 μM for one hour. Quantitative PCR (qPCR) was employed to measure mRNA expression levels for (<b>a</b>) TRP-1, (<b>b</b>) TRP-2, and (<b>c</b>) tyrosinase. Additionally, Western blot analysis was conducted to evaluate protein levels of (<b>d</b>) TRP-1, (<b>e</b>) TRP-2, (<b>f</b>) tyrosinase, and (<b>g</b>) p-MITF across groups (n = 3/group). In all panels, the white bar represents the untreated control group (no α-MSH stimulation), the black bar represents the α-MSH-stimulated control group, and the dark gray bars indicate the 10E-PDA-treated groups (α-MSH-stimulated). Results are presented as mean ± SEM. <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05, <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01 and <sup>###</sup> <span class="html-italic">p</span> &lt; 0.001 compared with the non-treated control group, and * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01 and *** <span class="html-italic">p</span> &lt; 0.001 compared with the α-MSH-treated group.</p>
Full article ">Figure 5
<p>Effects of 10E-PDA on MITF translocation. Immunofluorescence analysis was performed to evaluate the inhibitory effect of 10E-PDA on the nuclear translocation of MITF. B16F10 cells were treated with 10E-PDA (5 and 15 μM) and linolenic acid (15 μM), and fluorescence microscopy evaluation was performed. MITF was detected using anti-MITF monoclonal antibody and then detected using FSD<sup>TM</sup>-conjugated secondary antibody. This analysis revealed the localization of MITF, thereby elucidating the effect of 10E-PDA on MITF nuclear translocation (Scale bars represent 200 μm).</p>
Full article ">
21 pages, 2267 KiB  
Article
Multifunctional, Novel Formulation for Repairing Photoaged and Sun-Damaged Skin: Insights from In Vitro, Ex Vivo, and In Vivo Studies
by María Moneo-Sánchez, Nagore de Pablo, Leire Arana-Pascual, Itziar Beitia, Sandra Benito-Cid and Raúl Pérez-González
Cosmetics 2024, 11(6), 224; https://doi.org/10.3390/cosmetics11060224 - 17 Dec 2024
Viewed by 86
Abstract
Prolonged sun exposure disrupts the skin’s structural, mechanical, and functional properties, accelerating aging and contributing to skin disorders. To counteract these effects, we developed a formulation containing potent antioxidant, anti-inflammatory, moisturizing, and reparative ingredients to protect and repair sun-damaged skin. The efficacy of [...] Read more.
Prolonged sun exposure disrupts the skin’s structural, mechanical, and functional properties, accelerating aging and contributing to skin disorders. To counteract these effects, we developed a formulation containing potent antioxidant, anti-inflammatory, moisturizing, and reparative ingredients to protect and repair sun-damaged skin. The efficacy of the formulation was evaluated through in vitro, ex vivo, and in vivo studies. Results demonstrated that the formulation reduced oxidative stress and suppressed the production of pro-inflammatory cytokines interleukin-6 (IL-6) and interleukin-8 (IL-8), as well as lactate dehydrogenase (LDH) secretion, in a photodamaged skin model, nearly reaching levels observed in undamaged skin. It also restored collagen levels, improving structural integrity. In vivo, no adverse reactions were observed when used for 28 or 56 days. The formulation improved skin hydration by up to 46%, reduced transepidermal water loss by 20%, increased luminosity by 70%, and reduced hyperpigmented spots by 14%. It also enhanced skin firmness and elasticity by 30% and reduced wrinkle volume and density by up to 53% and 19%, respectively. These findings demonstrate that the formulation’s active ingredients effectively target the pathways altered by UV exposure, offering considerable potential for preventing and reversing sun-induced skin damage while improving both the appearance and functionality of the skin. Full article
(This article belongs to the Special Issue Skin Anti-Aging Strategies)
Show Figures

Figure 1

Figure 1
<p>Antioxidant activity of the product measured by DFFDA assay. Negative control (C−) represents a condition in which no product is added (0% antioxidant activity). Positive control (C+) represents a condition in which ascorbic acid 50 mM is added. Concentration values are expressed as % volume/volume. Asterisks (***) indicate a statistically significant difference (<span class="html-italic">p</span> &lt; 0.001) compared to the negative control (C−) group.</p>
Full article ">Figure 2
<p>Inflammation in photoaged human skin explants. IL-6 (<b>a</b>) and IL-8 (<b>b</b>) secretion levels in non-irradiated control human skin explants (Control), explants exposed to UV-Vis light (Photoaged), or skin explants exposed to UV-Vis light and treated with the product (Photoaged + Product) after 9 days. Asterisks indicate a statistically significant difference (* <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01) compared to the Control group. Pounds indicate a statistically significant difference (# <span class="html-italic">p</span> &lt; 0.05) compared to the Photoaged group.</p>
Full article ">Figure 3
<p>Tissue damage in photoaged human skin explants. Tissue damage, measured by LDH leakage, of human skin explants (hOSECs) that were either non-irradiated (Control), exposed to UV-Vis light (Photoaged), or exposed to UV-Vis light and treated with the product (Photoaged + Product) after 9 days. Results were normalized to 100% LDH concentration based on non-irradiated control skin explants. Asterisks indicate a statistically significant difference (** <span class="html-italic">p</span> &lt; 0.01) compared to the Control group. Pounds indicate a statistically significant difference (# <span class="html-italic">p</span> &lt; 0.05) compared to the Photoaged group.</p>
Full article ">Figure 4
<p>Collagen content of photoaged human skin explants. Collagen levels in non-irradiated control hOSECs (Control), hOSECs exposed to UV-Vis light (Photoaged), and hOSECs exposed to UV-Vis light and treated with the product (Photoaged + Product) after 9 days. Results were normalized to 100% collagen content based on non-irradiated control skin explants. Asterisks indicate a statistically significant difference (* <span class="html-italic">p</span> &lt; 0.05) compared to the Control group.</p>
Full article ">Figure 5
<p>Representative image of depigmenting efficacy in a volunteer. The image depicts a pigmented area at initial day (T0) on the left, and at final day (T56D) on the right.</p>
Full article ">Figure 6
<p>Anti-wrinkle efficacy (AEVA-HE images). Three-dimensional scanning sensor images, where wrinkles are shown in pink for three different volunteers before (T0) and after 56 days of product application (T56D).</p>
Full article ">Figure 7
<p>Anti-wrinkle efficacy (Dermatological evaluation). Wrinkle severity was evaluated by a dermatologist. Percentage of forehead wrinkles (<b>a</b>) and frown lines (<b>b</b>) rated at higher (dark orange) and lower (light orange) severity levels are shown for initial day (T0), day 28 (T28D), and day 56 (T56D).</p>
Full article ">Figure 8
<p>Subjective evaluation of efficacy. The percentage of volunteers who agree or disagree with each statement is shown.</p>
Full article ">
11 pages, 2334 KiB  
Article
Skin Barrier-Improving and Skin-Soothing Effects of Autophagy-Activating Peptide on Sensitive Skin
by Sohee Eun, Minhye Lim, Juyeon Jung, Kayoung Shin, Sungwoo Kim, Yeonjae Kim, Gaewon Nam, Sekyoo Jeong and Hyunjung Kim
Cosmetics 2024, 11(6), 223; https://doi.org/10.3390/cosmetics11060223 - 17 Dec 2024
Viewed by 109
Abstract
Among the complex and diverse triggering and aggravating factors for sensitive skin syndrome, potential defects in skin barrier function are considered one of the most important ones. Previously, we have reported improvements in skin barrier function thanks to autophagy-activating peptide derivatives. Further investigation [...] Read more.
Among the complex and diverse triggering and aggravating factors for sensitive skin syndrome, potential defects in skin barrier function are considered one of the most important ones. Previously, we have reported improvements in skin barrier function thanks to autophagy-activating peptide derivatives. Further investigation revealed that the activation of autophagy signaling in skin cells also attenuated inflammatory responses induced by UV irradiation or exposure to pollution. In this study, in vitro and ex vivo human skin explant models were used to evaluate the potential benefits of the autophagy-activating peptide, pentasodium tetracarboxymethyl palmitoyl didpeptide-12 (PTPD-12), on sensitive skin-related parameters. Clinical efficacy testing was also performed to confirm the skin barrier-improving and skin-soothing activities of the autophagy-activating peptide. As a result, significant reductions in inflammatory cytokine (IL-8 and TNF-α) and enzyme activity (PDE4) were observed in the in vitro system. Increased expression of barrier marker proteins by PTPD-12 in UV-irradiated human skin tissue was observed ex vivo. In a clinical study, delayed response to topical capsaicin-induced vascular activation, which represents enhanced epidermal permeability barrier function, was observed after 4 weeks of application of PTPD-12 in healthy volunteers. In another clinical study with sensitive skin carriers identified via a lactic acid stinging test, a significant reduction in trans-epidermal water loss (TEWL) and skin erythema index was observed after 4 weeks of PTPD-12 usage. These results suggest that the activation of autophagy can be a potential treatment regimen for sensitive skin syndrome, specifically in terms of skin barrier function enhancement and skin soothing. Full article
Show Figures

Figure 1

Figure 1
<p>Stimulation of autophagy by topical application of autophagy activator in ex vivo human skin tissue. Expression of LC3B protein, marker of autophagy activity, was downregulated by UVB irradiation, and topical application of PTPD-12 significantly upregulated LC3B expression (magnification: ×400) (dotted line: dermal–epidermal junction; green: LC3B; blue: DAPI).</p>
Full article ">Figure 2
<p>Attenuation of inflammatory cytokine production by autophagy activator. Increased expressions of interleukin-8 (IL-8) in cultured primary human epidermal keratinocytes (HEKs) induced either by tumor necrosis factor-a (TNF-α) (100 ng/mL) (<b>a</b>) or TNF-α (100 ng/mL)/IL-17A (50 ng/mL) treatment (<b>b</b>) were significantly attenuated by co-treatment of autophagy activator PTPD-12 (10 μM).</p>
Full article ">Figure 3
<p>The anti-inflammatory activity of the autophagy activator in UVB-induced skin irritation. While a significant increase in both TNF-α (<b>upper panel</b>) (dotted line: dermal–epidermal junction; red: TNF- α; blue: DAPI) and PDE4A (<b>lower panel</b>) was observed after UVB irradiation, topical application of the autophagy activator reduced both proteins in the whole epidermis (magnification: ×400).</p>
Full article ">Figure 4
<p>Upregulation of differentiation marker protein expression by autophagy activator. Significant increase in filaggrin (<b>upper panel</b>) (dotted line: dermal–epidermal junction; green: filaggrin; blue: DAPI) and loricrin (<b>lower panel</b>) (dotted line: dermal–epidermal junction; green: loricrin; blue: DAPI) expressions due to topical application of autophagy activator was observed (magnification: ×400).</p>
Full article ">
6 pages, 1932 KiB  
Case Report
Tunnel Infection and Peritonitis Induced by Staphylococcus aureus Due to Decubitus Change of the Anterior Abdominal Wall in a Patient on Peritoneal Dialysis: Case Report
by Marko Baralić, Ana Bontić, Jelena Pavlović, Vidna Karadžić-Ristanović, Selena Gajić, Jovan Jevtić, Pavle Popović, Kristina Petrović, Lara Hadži-Tanović and Aleksandra Kezić
Microorganisms 2024, 12(12), 2608; https://doi.org/10.3390/microorganisms12122608 - 17 Dec 2024
Viewed by 113
Abstract
The occurrence of anterior abdominal wall ulcer at the site of the peritoneal catheter (PC) is one of the rarest complications of peritoneal dialysis (PD). When present, it is mainly caused by staphylococci which respond well to vancomycin therapy. Despite well-conducted therapy, there [...] Read more.
The occurrence of anterior abdominal wall ulcer at the site of the peritoneal catheter (PC) is one of the rarest complications of peritoneal dialysis (PD). When present, it is mainly caused by staphylococci which respond well to vancomycin therapy. Despite well-conducted therapy, there is a tendency to relapse and induce peritonitis, which makes it necessary to remove the PC and change the dialysis model of treatment and/or re-insert the catheter at another place to preserve PD as a treatment method. In the present study, we discuss a case of a 53-year-old patient with end-stage kidney disease treated with PD and with decubitus changes at the PC exit site; the change occurred due to migration of the catheter middle part by protruding from the abdominal cavity to the skin, thus allowing ulcer appearance. Although the PC site was treated with antibiotics, as advised by the surgeon, the patient was finally transferred to hemodialysis as the repositioning of the catheter was not performed. This leads to the conclusion that the antibiotic treatment and catheter repositioning are mandatory to preserve peritoneal dialysis as an end-stage kidney disease (ESKD) treatment model. Full article
(This article belongs to the Special Issue Human Skin Microbiota, 2nd Edition)
Show Figures

Figure 1

Figure 1
<p>An extruded subcutaneous cuff (red arrow) ulceration and granulation tissue (black arrow) present on peritoneal catheter exit site. A photo was taken from two angles to clearly represent the observed change (<b>A</b>,<b>B</b>).</p>
Full article ">Figure 2
<p>The granulation tissue (black arrow) at the catheter exit site and ulceration (red arrow) (<b>A</b>) in the catheter tunnel region (the path of the catheter tunnel is marked with two parallel lines) (<b>B</b>).</p>
Full article ">Figure 3
<p>The granulation tissue (black arrow) at the catheter exit site and ulceration (red arrow) (<b>A</b>) in the catheter tunnel region (the path of the catheter tunnel is marked by lines) (<b>B</b>).</p>
Full article ">
11 pages, 1007 KiB  
Brief Report
Patients’ Acceptance of Psoriasis Depends on Disease Severity, Itch Intensity, and the Patients’ Quality of Life: A Cross-Sectional Study
by Beata Bień, Piotr K. Krajewski and Jacek C. Szepietowski
J. Clin. Med. 2024, 13(24), 7684; https://doi.org/10.3390/jcm13247684 - 17 Dec 2024
Viewed by 110
Abstract
Background/Objectives: Psoriasis is a chronic skin disorder affecting over 60 million people worldwide, with both physical and psychological impacts due to the visible lesions and associated somatic symptoms. This study aimed to assess disease acceptance among psoriasis patients and to explore its correlation [...] Read more.
Background/Objectives: Psoriasis is a chronic skin disorder affecting over 60 million people worldwide, with both physical and psychological impacts due to the visible lesions and associated somatic symptoms. This study aimed to assess disease acceptance among psoriasis patients and to explore its correlation with disease severity, itch intensity, and quality of life (QoL) Methods: The study included 166 psoriasis patients, comprising 101 men and 65 women, all with a disease duration of at least one year. Clinical and psychological aspects of psoriasis were comprehensively assessed using various standardized tools, along with a demographic questionnaire. Results: The study found that psoriasis patients had a mean illness acceptance score of 25.1 points, with most respondents (44%) exhibiting a moderate level of acceptance. A high level of acceptance was observed in 28% of participants, while an equal proportion of patients (28%) demonstrating low acceptance, with no significant gender-based differences. Acceptance was negatively correlated with disease severity (PASI score), quality of life impairment (DLQI), and itch intensity (NRS), indicating that lower acceptance was linked to more severe symptoms. Additionally, a slight negative correlation was observed between acceptance and disease duration, while acceptance levels were unaffected by factors such as education, relationship status, or age of disease onset. Conclusions: A comprehensive approach to psoriasis treatment should address not only the physical aspects but also the psychological challenges faced by patients, with a particular focus on improving disease acceptance as a coping strategy. Reducing itch intensity may contribute to better disease acceptance. Full article
Show Figures

Figure 1

Figure 1
<p>Percentage of patients’ answers on the Acceptance of Illness Scale.</p>
Full article ">Figure 2
<p>Acceptance of Illness Scale correlation with different clinical aspects.</p>
Full article ">
23 pages, 5099 KiB  
Article
Study on the Effect of Local Heating Devices on Human Thermal Comfort in Low-Temperature Built Environment
by Yalong Yang, Nana Shi, Rui Zhang, Hanxiang Zhou, Lei Ding, Jiamin Tao, Nan Zhang and Bin Cao
Buildings 2024, 14(12), 3996; https://doi.org/10.3390/buildings14123996 - 17 Dec 2024
Viewed by 152
Abstract
Localized heating systems are an effective approach to improve thermal comfort while reducing energy consumption in a cold indoor environment. Furthermore, localized heating devices have found widespread application in the hot-summer and cold-winter zones of China. This study investigates the heating characteristics of [...] Read more.
Localized heating systems are an effective approach to improve thermal comfort while reducing energy consumption in a cold indoor environment. Furthermore, localized heating devices have found widespread application in the hot-summer and cold-winter zones of China. This study investigates the heating characteristics of the local heating device in a low-temperature environment, as well as its effects on subjective perception and physiological responses, and develops a personalized control system for the device based on the experimental findings. We conducted experimental tests and questionnaires in a test room with air temperature set at 12 °C and 14 °C and a relative humidity of 55%. A total of six experimental conditions were designed using five types of heating equipment (heating wrist straps, heating insoles, heating leg straps, warm air blower, electric radiant heater), each employing different heat transfer methods. The results demonstrate that the head, hands, legs, and feet are susceptible to feeling cold in a low-temperature environment, and the use of a warm air blower and electric radiant heater can significantly enhance the thermal sensation of these parts, improve thermal acceptability, and raise local skin temperature. The electrocardiogram data indicate that heart rate variability can be utilized to assess thermal sensation in a cold environment with localized heating. Additionally, the relationship between thermal response and skin temperature was investigated, leading to the development of a control strategy for the local heating device in a low-temperature conditions. Full article
Show Figures

Figure 1

Figure 1
<p>The plan view of the test room.</p>
Full article ">Figure 2
<p>Local heating equipment and their placement when in use. (<b>a</b>) Heating wristband, (<b>b</b>) heating leg band, (<b>c</b>) heating insole, (<b>d</b>) warm air blower, and (<b>e</b>) electric radiant heater.</p>
Full article ">Figure 3
<p>Experimental procedure.</p>
Full article ">Figure 4
<p>Schematic diagram of ECG equipment.</p>
Full article ">Figure 5
<p>Local skin temperature and mean skin temperature.</p>
Full article ">Figure 6
<p>Overall thermal sensation vote at 12 °C and 14 °C.</p>
Full article ">Figure 7
<p>Overall thermal comfort vote at 12 °C and 14 °C.</p>
Full article ">Figure 8
<p>LTSV at 12 °C and 14 °C.</p>
Full article ">Figure 9
<p>LTCV at 12 °C and 14 °C.</p>
Full article ">Figure 10
<p>Thermal preference vote at 12 °C and 14 °C.</p>
Full article ">Figure 11
<p>Thermal acceptance at 12 °C and 14 °C.</p>
Full article ">Figure 12
<p>Heart rate variability and subjective thermal sensation. (<b>a</b>) HRV and thermal sensation vote results; (<b>b</b>) HRV and thermal sensation vote fitting curve.</p>
Full article ">Figure 13
<p>Subjects’ evaluation of personal comfort system.</p>
Full article ">Figure 14
<p>PCS control strategy based on overall thermal sensation prediction.</p>
Full article ">
Back to TopTop